R & D- medical: biomedical (basic research)

Ended Definitive Contract Awarded Last action

Contract number
HHSN261201300087C
Awardee
Awarding agency
Obligated
$1,499,990

Award facts

Opportunity
  • N44C03101451 Solicitation number
Contract value 100% obligated
$1,499,990.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 4 offers Negotiated Proposal / Quote
Pricing
Cost Plus Award Fee
Place of performance
Nashville, TN 37217, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 1 $0
Original award $1,499,990

About this award

The U.S. National Cancer Institute (NCI) awarded a $1,499,990.00 cost-plus-award-fee contract to Insight Genetics, Inc. for research and development in the biomedical basic research field. The contract, which has a performance period through September 19, 2015, was awarded on September 20, 2013 and does not have a set-aside designation. While the original solicitation is not provided, this contract appears to be part of the NCI's larger research and development efforts in the medical and biomedical fields.

Quick answers

Who was awarded contract HHSN261201300087C?

HHSN261201300087C was awarded to Insight Genetics, Inc. by National Cancer Institute (National Institutes of Health) on September 20, 2013.

How much is contract HHSN261201300087C worth?

The government has obligated $1,499,990 on HHSN261201300087C.

Was contract HHSN261201300087C competed?

The extent of competition for HHSN261201300087C was full and open competition. The government received 4 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award